NeoGenomics, Inc. operates a network of clinical laboratories specializing in diagnostic testing for hereditary cancer. The company’s services include cytogenetics, fluorescence in situ hybridization (FISH), flow cytometry, morphology, anatomic pathology, and molecular genetic testing.
Get AI Stock Predictions Now
Download our app for real-time AI-powered stock predictions on iOS, Android, Windows and macOS
Disclaimer: AI-generated stock predictions are for informational purposes only and do not constitute financial advice. Past performance does not guarantee future results. Always do your own research and consult a qualified financial advisor before making investment decisions. Investing involves risk, including possible loss of principal.